BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 14505325)

  • 21. Designer drug 2,5-dimethoxy-4-methyl-amphetamine (DOM, STP): involvement of the cytochrome P450 isoenzymes in formation of its main metabolite and detection of the latter in rat urine as proof of a drug intake using gas chromatography-mass spectrometry.
    Ewald AH; Puetz M; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 862(1-2):252-6. PubMed ID: 18155651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).
    Meyer MR; Holderbaum A; Kavanagh P; Maurer HH
    J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450 dependent metabolism of the new designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP). In vivo studies in Wistar and Dark Agouti rats as well as in vitro studies in human liver microsomes.
    Staack RF; Paul LD; Springer D; Kraemer T; Maurer HH
    Biochem Pharmacol; 2004 Jan; 67(2):235-44. PubMed ID: 14698036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Sauer C; Peters FT; Haas C; Meyer MR; Fritschi G; Maurer HH
    J Mass Spectrom; 2009 Jun; 44(6):952-64. PubMed ID: 19241365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques.
    Jung J; Meyer MR; Maurer HH; Neusüss C; Weinmann W; Auwärter V
    J Mass Spectrom; 2009 Oct; 44(10):1423-33. PubMed ID: 19728318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake: use as adulterant of cocaine resulting in drug-drug interactions?
    Staack RF; Paul LD; Schmid D; Roider G; Rolf B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):127-33. PubMed ID: 17574934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).
    Meyer MR; Mauer S; Meyer GM; Dinger J; Klein B; Westphal F; Maurer HH
    Drug Test Anal; 2014; 6(7-8):746-56. PubMed ID: 24124065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques.
    Theobald DS; Pütz M; Schneider E; Maurer HH
    J Mass Spectrom; 2006 Jul; 41(7):872-86. PubMed ID: 16810648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.
    Wink CS; Meyer GM; Wissenbach DK; Jacobsen-Bauer A; Meyer MR; Maurer HH
    Drug Test Anal; 2014 Oct; 6(10):1038-48. PubMed ID: 24591097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designer drug 2,4,5-trimethoxyamphetamine (TMA-2): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Ewald AH; Fritschi G; Maurer HH
    J Mass Spectrom; 2006 Sep; 41(9):1140-8. PubMed ID: 16810708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS.
    Vorce SP; Holler JM; Levine B; Past MR
    J Anal Toxicol; 2008; 32(6):444-50. PubMed ID: 18652752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.
    Peters FT; Schaefer S; Staack RF; Kraemer T; Maurer HH
    J Mass Spectrom; 2003 Jun; 38(6):659-76. PubMed ID: 12827635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry.
    Ewald AH; Ehlers D; Maurer HH
    Anal Bioanal Chem; 2008 Apr; 390(7):1837-42. PubMed ID: 18259731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation, identification and excretion profile of the principal urinary metabolite of the recently banned designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP) in rats.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nakajima K; Inoue H; Kishi T; Tsuchihashi H
    Xenobiotica; 2005 Jan; 35(1):107-16. PubMed ID: 15788372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the metabolism and toxicological detection of glaucine, an isoquinoline alkaloid from Glaucium flavum (Papaveraceae), in rat urine using GC-MS, LC-MS(n) and LC-high-resolution MS(n).
    Meyer GM; Meyer MR; Wissenbach DK; Maurer HH
    J Mass Spectrom; 2013 Jan; 48(1):24-41. PubMed ID: 23303745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry.
    Staack RF; Fehn J; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(1):27-41. PubMed ID: 12726841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS.
    Meyer MR; Schmitt S; Maurer HH
    J Mass Spectrom; 2013 Feb; 48(2):243-9. PubMed ID: 23378097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
    Meyer MR; Dinger J; Schwaninger AE; Wissenbach DK; Zapp J; Fritschi G; Maurer HH
    Anal Bioanal Chem; 2012 Jan; 402(3):1249-55. PubMed ID: 22065349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometry.
    Staack RF; Theobald DS; Maurer HH
    Ther Drug Monit; 2004 Aug; 26(4):441-9. PubMed ID: 15257075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry.
    Springer D; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):253-66. PubMed ID: 14581066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.